Ambulatory Anesthesia Associates is categorized under Anesthesiologists in Rocky Point, NY and active since 2012.
Ambulatory Anesthesia Associates was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Anesthesiologists business, which does work in the B2C market, and is classified as a Anesthesiologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Frederic J Matlin at the company’s single location by writing to 333 Route 25a # 225, Rocky Point, New York NY 11778 or by phoning (631) 736-4064. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ambulatory Anesthesia Associates |
| Contact Person: | Frederic J Matlin |
| Address: | 333 Route 25a # 225, Rocky Point, New York 11778 |
| Phone Number: | (631) 736-4064 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Anesthesiologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Ambulatory Anesthesia Associates was started in 2012 to provide professional Anesthesiologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Frederic J Matlin for inquiries that concern Ambulatory Anesthesia Associates by calling the company number (631) 736-4064, as your correspondence is most welcome. Additionally, the physical location of the single location of Ambulatory Anesthesia Associates can be found at the coordinates 40.945108,-72.943958 as well as the street address 333 Route 25a # 225 in Rocky Point, New York 11778.
For its online presence, you may visit Ambulatory Anesthesia Associates’s website at and engage with its social media outlets through on Twitter and on Facebook.